GlassScriptPhysician profile
Fenton Harrison Mccarthy
NPI 1114245032
$41,261.02
in general payments reported to CMS, 2019-2025
29 companies · $5,957 in 2025
The $5,957 reported for 2025 was more than what 84% of Thoracic Surgery (Cardiothoracic Vascular Surgery) providers received nationally (typical 2025 total: $796).
See the full distribution for Thoracic Surgery (Cardiothoracic Vascular Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,973 · 2020: $1,373 · 2021: $1,232 · 2022: $24K · 2023: $2,877 · 2024: $984 · 2025: $5,957.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $5,500 · Food and Beverage: $4,318.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $5,500.35 |
| Food and Beverage | $4,317.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $22,186.02 | 2022-2023 | Impella |
| Bolton Medical INC | $4,178.73 | 2019-2025 | Treo Abdominal Stent-Graft System, Thoraflex Hybrid |
| Edwards Lifesciences Corporation | $4,041.28 | 2019-2025 | Pascal, Mitris Resilia Mitral Valve, Konect Resilia |
| Artivion, INC. | $3,652.14 | 2025 | Cardiac Non-Synergraft, Amds-Ascyrus Medical, Cryovalve Sg Pulmonary Human Heart Valve |
| Medtronic Vascular, INC. | $1,985.07 | 2019-2020 | |
| Abbott Laboratories | $1,351.43 | 2019-2025 | Epic |
| Haemonetics Corporation | $800.33 | 2021-2024 | Teg6s Hemostasis System |
| Boston Scientific Corporation | $558.89 | 2019-2022 | |
| Medtronic, INC. | $538.68 | 2022-2025 | Avalus, Selectsecure, Tri-Ad |
| W. L. Gore & Associates, INC. | $338.66 | 2023-2025 | Excluder Conformable Aaa Endoprosthesis With Active Control, Gore Tag Conformable Thoracic Stent Graft, Gore Tag Conformable Thoracic Endoprosthesis |
| Baxter Healthcare | $274.39 | 2022-2024 | Hillrom - Cardiac Ambulatory Monitor, Floseal |
| Atricure, INC. | $233.77 | 2022-2024 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $173.98 | 2019-2020 | |
| Getinge USA Sales, LLC | $153.15 | 2021 | |
| Ethicon US, LLC | $142.53 | 2019-2022 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Terumo Cardiovascular Systems Corporation | $130.92 | 2019 | |
| Werfen USA LLC | $90.59 | 2021 | |
| Amgen INC. | $77.67 | 2019-2023 | Repatha |
| Kls-Martin L.P. | $59.27 | 2019-2020 | |
| Livanova USA, INC. | $53.99 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $47.67 | 2019-2022 | |
| Angiodynamics, INC. | $45.91 | 2020 | |
| Lemaitre Vascular, INC. | $37.71 | 2024 | Artegraft Vascular Graft, Anastoclip Gc 8cm (Medium) |
| Janssen Pharmaceuticals, INC | $28.35 | 2023 | Xarelto |
| E.R. Squibb & Sons, L.L.C. | $19.66 | 2023 | Camzyos |
| Pfizer INC. | $18.67 | 2023 | |
| Chiesi USA, INC. | $14.29 | 2024 | Cleviprex, Kengreal |
| Novartis Pharmaceuticals Corporation | $13.72 | 2022 | |
| Merck Sharp & Dohme LLC | $13.55 | 2023 | Verquvo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Fenton Mccarthy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.